New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
September 20, 2024 - The FDA announced the approval of AstraZeneca’s FluMist (influenza vaccine live) intranasal spray, for self- or caregiver-administration.
Download PDF
Return to publications
